Epidemic

Joint Statement from the Co-Chairs of the Special Advisory Committee on the Epidemic of Opioid Overdoses - Latest National Data on Substance-Related Harms

Retrieved on: 
Thursday, September 28, 2023
Epidemic, Learning, Special Advisory Committee, Tic disorder, Homelessness, Harm, Friends, Naloxone, COVID-19, Statistics, Language, Fourth, Death, Student, Grief, Social isolation, Risk, Love, Drug, Mortality, Trauma, Safety, Medical device, Birth control, Hospital, Dietary supplement, Nursing

This release provides an update on data collected from January to March 2023 and builds on historical data that has been collected every quarter since 2016.

Key Points: 
  • This release provides an update on data collected from January to March 2023 and builds on historical data that has been collected every quarter since 2016.
  • These latest data suggest that in Canada between January and March 2023, there were 1,904 opioid-related deaths – or an average of 21 deaths per day.
  • This represents a similar mortality rate to what has been observed since the start of the COVID-19 pandemic, when the number of opioid-related deaths increased.
  • The report highlights that repeat interactions with the healthcare system could provide opportunities to support individuals experiencing substance-related harms.

WestRock Announces Results of Consent Solicitation

Retrieved on: 
Wednesday, September 27, 2023
Other Manufacturing, Packaging, Engineering, Chemicals, Plastics, Manufacturing, Other Natural Resources, Machinery, Forest Products, Natural Resources, Uncertainty, National Storage, Coronavirus, Policy, COVID-19, WestRock, OR, Cyclone, SKG, Epidemic, Prospectus, Pandemic, ANY, Power, United Kingdom, Government, Security (finance), Health, Safety, Risk management

These forward-looking statements generally include statements regarding WestRock’s and SKG’s future expectations, beliefs, plans, objectives, results of operations, financial condition and cash flows, or future events or performance.

Key Points: 
  • These forward-looking statements generally include statements regarding WestRock’s and SKG’s future expectations, beliefs, plans, objectives, results of operations, financial condition and cash flows, or future events or performance.
  • Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions.
  • Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.
  • We can give no assurance that such plans, estimates or expectations will be achieved and therefore, actual results may differ materially from any plans, estimates or expectations in such forward-looking statements.

Dr. Sheena Menezes, CEO and Co-Founder of Simple HealthKit, Named One of Fierce Healthcare’s Most Influential Minority Executives in Healthcare

Retrieved on: 
Monday, September 18, 2023
Diabetes, Pharmacy, Public, COVID-19, University, Health equity, Simple, Research, Health (Apple), Epidemic, RSV, Fierce, Physician, Cancer, Entrepreneurship, Government, Health, Geography, Nursing, Health care

In its fourth annual Most Influential Minority Executives in Healthcare awards, Fierce spotlights 10 leaders across the industry who are shaping the way healthcare of the future will be delivered.”

Key Points: 
  • In its fourth annual Most Influential Minority Executives in Healthcare awards, Fierce spotlights 10 leaders across the industry who are shaping the way healthcare of the future will be delivered.”
    Dr. Menezes has a mission to bring health equity to all, especially underserved and vulnerable communities.
  • She is passionate about promoting access to better health for everyone, regardless of socioeconomic status, or geography.
  • “I am humbled to receive this recognition from Fierce Healthcare as a testament to the hard work our whole team at Simple HealthKit has been doing this year to address health inequity,” said Dr. Sheena Menezes, CEO and Co-Founder of Simple HealthKit.
  • At Simple HealthKit we will continue to innovate with our end-to-end healthcare platform that provides diagnostics, treatment and follow-up care and reach more communities in need of high-quality, affordable healthcare.”

BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission

Retrieved on: 
Monday, September 18, 2023
Vaccine, Epidemic, BioNTech, Partnership, Vaccination, Public, Coalition, CEPI, Infection, Clinical trial, Malaria, Coalition for Epidemic Preparedness Innovations, Smallpox, History, Messenger, G7, MPXV, Monkeypox virus, Mpox, BNTX, G20, Knowledge, Pregnancy, Immunodeficiency, Virus, Safety, Tuberculosis, Orthopoxvirus

Since the eradication of smallpox in 1980, the global population-level immunity against the Orthopoxvirus viral family, including mpox, has been waning3.

Key Points: 
  • Since the eradication of smallpox in 1980, the global population-level immunity against the Orthopoxvirus viral family, including mpox, has been waning3.
  • BioNTech is aiming to develop a prophylactic mRNA-based mpox vaccine with a favorable safety profile that can be manufactured at scale.
  • The partnership between BioNTech and CEPI could help accelerate responses to future outbreaks caused by viruses of the Orthopoxvirus viral family in several ways.
  • BioNTech and CEPI are committed to enabling equitable access to the outputs of this partnership.

 WestRock Announces Consent Solicitation

Retrieved on: 
Wednesday, September 20, 2023
Forest Products, Packaging, Natural Resources, Manufacturing, Communication, Smurfit Kappa, Coronavirus, Accounting, Pandemic, Risk, Government, Consent, National Storage, Policy, OR, Attention, Epidemic, Power, Security (finance), Safety, Uncertainty, COVID-19, WestRock, Dynamic consent, Holder, Expiration, Cyclone, Eric Holder, SKG, Prospectus, ANY, United Kingdom, Health, Veni, vidi, vici, Solicitation, Property management, Mergers and acquisitions, Indenture, Note, Issuer

WestRock Company (“WestRock”) announced today that its wholly-owned subsidiary WRKCo Inc. (the “Issuer”) commenced a consent solicitation through which it is soliciting consents (“Consents”) from registered holders (“Holders”) of the Notes (the “Consent Solicitation”) to amend certain terms of the indentures governing the respective Notes (each, an “Indenture” and together, the “Indentures”).

Key Points: 
  • WestRock Company (“WestRock”) announced today that its wholly-owned subsidiary WRKCo Inc. (the “Issuer”) commenced a consent solicitation through which it is soliciting consents (“Consents”) from registered holders (“Holders”) of the Notes (the “Consent Solicitation”) to amend certain terms of the indentures governing the respective Notes (each, an “Indenture” and together, the “Indentures”).
  • The terms and conditions of the Consent Solicitation are set forth in a consent solicitation statement dated as of September 20, 2023 (as it may be amended and supplemented from time to time, the “Consent Solicitation Statement”).
  • The Consent Solicitation will expire at 5:00 p.m., New York time, on September 26, 2023, unless the Consent Solicitation is extended or earlier terminated by the Issuer for any or all series of the Notes in its sole discretion (the “Expiration Time”).
  • The Consent Solicitation is only being made pursuant to the terms of the Consent Solicitation Statement.

Rocket Lab Launch Update

Retrieved on: 
Tuesday, September 19, 2023
Technology, Aerospace, Manufacturing, Satellite, Lab, Capella Space, Electron, Spacecraft, FAA, Epidemic, Pandemic, Launch Complex 1, Risk, Security (finance), Rocket Lab, Environment, Maintenance (technical), Risk management

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), today experienced an issue during the launch of the Company’s 41st mission.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), today experienced an issue during the launch of the Company’s 41st mission.
  • These forward-looking statements are based on Rocket Lab’s current expectations and beliefs concerning future developments and their potential effects.
  • There can be no assurance that the future developments affecting Rocket Lab will be those that we have anticipated.
  • Except as required by law, Rocket Lab is not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

African leaders warn of deadly malaria emergency and call for urgent action to address unprecedented funding shortfall

Retrieved on: 
Saturday, September 23, 2023
Private sector, Emergency, United Nations, Failure, TB, Agenda 2063, African Leaders Malaria Alliance, World Bank Group, HE, IDA, Temperature, COVID, World Bank, United Nations General Assembly, Government, United Nations Office for the Coordination of Humanitarian Affairs, Public sector, Epidemic, Drug resistance, Republic, Climate change, Risk, Child, UN, Excellency, African Union, UHC, Guinea-Bissau, Weather, African Union Commission, Health, Neglected tropical diseases, Disease, AU, Insecticide, Vaccine, Pharmaceutical industry, Renewable energy, State, Malaria

NEW YORK, Sept. 23, 2023 /PRNewswire-PRWeb/ -- African Union Heads of State and Government, global health leaders and development partners today issued a joint call for urgent action to address the looming malaria emergency. They warned that failure to act now will put at risk both the African Union's target of eliminating malaria in Africa by 2030, and the UN target of ending malaria epidemics by 2030.

Key Points: 
  • African Union Heads of State and Government, global health leaders and development partners today issued a joint call for urgent action to address the looming malaria emergency.
  • NEW YORK, Sept. 23, 2023 /PRNewswire-PRWeb/ -- African Union Heads of State and Government, global health leaders and development partners today issued a joint call for urgent action to address the looming malaria emergency.
  • "If we don't act swiftly to address the immediate gap of $1.5 billion and mobilise the necessary resources, we will undoubtedly see malaria upsurges and epidemics."
  • His Excellency President Umaro Sissoco Embaló, President of the Republic of Guinea-Bissau and Chair of the African Leaders Malaria Alliance painted an alarming picture: "We are at a critical juncture.

Global Animal Growth Promoters and Performance Enhancers Market Poised for 6.2% CAGR Growth from 2020-2026

Retrieved on: 
Tuesday, September 19, 2023
Poultry, Lead, Research, Hormone, Compound annual growth rate, Epidemic, SWOT, Climate change, Investment, Geography, Drug discovery, Growth, Ground substance, Meat, Egg, Pet industry, Agriculture

DUBLIN, Sept. 19, 2023 /PRNewswire/ -- The "Animal Growth Promoters and Performance Enhancers Market by Type, Animal, By Geography Global Opportunity Analysis and Industry Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 19, 2023 /PRNewswire/ -- The "Animal Growth Promoters and Performance Enhancers Market by Type, Animal, By Geography Global Opportunity Analysis and Industry Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The global Animal Growth Promoters and Performance Enhancers market is set to experience robust growth, with a projected Compound Annual Growth Rate (CAGR) of 6.2% during the period of 2020-2026.
  • Despite the promising growth, challenges remain, notably a lack of awareness among end-users about animal growth promoters and performance enhancers.
  • This report provides a comprehensive understanding of the Animal Growth Promoters and Performance Enhancers market, highlighting key trends, market dynamics, and the evolving needs of end-users.

PFSweb, Inc. to be Acquired by GXO Logistics, Inc.

Retrieved on: 
Thursday, September 14, 2023
LLP, Communication, Letter, Plan, Tripura Merger Agreement, PFSweb, COVID-19, Sub, PlayStation Vita system software, E-commerce, PFS, Sale, Schedule, Epidemic, VWAP, Internet, Pandemic, Acquisition, Annual report, GXO, Risk, Hart–Scott–Rodino Antitrust Improvements Act, United Kingdom, Growth, NYSE, Security (finance), Financial services, Asset management, Cryptocurrency, Transmittal document, Mergers and acquisitions, Merkle, Parent

IRVING, Texas, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PFSweb, Inc. (NASDAQ: PFSW) (the “Company” or “PFSweb”) has entered into an Agreement and Plan of Merger to be acquired by GXO Logistics, Inc. (NYSE: GXO) (“GXO”), the world’s largest pure-play contract logistics provider, for an equity value of approximately $181 million. The transaction is expected to close in the fourth quarter of 2023.

Key Points: 
  • The merger agreement provides for GXO, through a subsidiary, to commence a tender offer to acquire all outstanding shares of PFSweb at $7.50 per share in cash.
  • Upon completion of the tender offer, GXO will acquire all PFSweb shares not acquired in the tender through a second-step merger.
  • Upon closing the transaction, PFSweb will be removed from the Nasdaq Stock Exchange, and PFS will operate as a division within GXO.
  • Some additional transaction highlights include:
    Enhanced Fulfillment Offerings for Premier Brands: Providing premium order fulfillment and support services to both existing PFS clients and GXO eCommerce-centric clients.

Rocket Lab Signs Deal with Leidos to Launch Four HASTE Missions

Retrieved on: 
Tuesday, September 12, 2023
Technology, Aerospace, Manufacturing, Satellite, Neutron, NSWC, Naval Surface Warfare Center, U.S. Department of Defense Strategy for Operating in Cyberspace, Senior, Maritime Transportation Security Act of 2002, Lab, OTA, COVID-19, Launch Complex 2, Electron, Moon, Intelligence, Spacecraft, Multimedia, Launch, Epidemic, Pandemic, NASA, Risk, Strategy, Hypersonic speed, HASTE, Security (finance), Leidos, Rocket Lab, Mid-Atlantic Regional Spaceport Launch Pad 0, Environment, Communications satellite, Mars, Photon

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has signed a contract with Leidos to launch four HASTE (Hypersonic Accelerator Suborbital Test Electron) missions.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has signed a contract with Leidos to launch four HASTE (Hypersonic Accelerator Suborbital Test Electron) missions.
  • The missions, scheduled across 2024 and 2025, will lift off from Rocket Lab Launch Complex 2 at Virginia’s Mid-Atlantic Regional Spaceport within NASA’s Wallops Flight Facility.
  • Rocket Lab was selected by Leidos to provide hypersonic test launch capabilities with HASTE under the MACH-TB project.
  • Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia.